Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone ResistancePatrick N. A. Harris, David L. Paterson, Souha S. Kanj et al.|JAMA|2018Cited by 761
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyAndrew Henderson, Bassam Alalwan, David L. Paterson et al.|Clinical Infectious Diseases|2020Cited by 155
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27Patrick N. A. Harris, Tony M. Korman, Nouri L. Ben Zakour et al.|Journal of Antimicrobial Chemotherapy|2017Cited by 82
Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditisSimon Briggs, Hasan Bhally, Matthew A. Broom et al.|Journal of Antimicrobial Chemotherapy|2021Cited by 18
Outpatient parenteral antimicrobial therapy for patients with <i>Enterococcus faecalis</i> endocarditis using continuous infusion IV benzylpenicillin plus IV ceftriaxoneSimon Briggs, Simon C. Dalton, Eamon Duffy et al.|JAC-Antimicrobial Resistance|2024Cited by 3